CME Group (NASDAQ:CME) Price Target Lowered to $302.00 at Jefferies Financial Group

CME Group (NASDAQ:CME) had its price target dropped by analysts at Jefferies Financial Group from $304.00 to $302.00 in a report released on Monday,MarketScreener reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. Jefferies Financial Group’s price target points to a potential upside of 10.79% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. Raymond James Financial upped their price objective on shares of CME Group from $307.00 to $311.00 and gave the company an “outperform” rating in a report on Monday, January 5th. The Goldman Sachs Group decreased their target price on CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a research report on Wednesday. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Bank of America boosted their price objective on CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Finally, Cowen raised CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Ten research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $291.82.

CME Group Trading Down 1.0%

NASDAQ CME traded down $2.64 during trading hours on Monday, hitting $272.59. 1,673,475 shares of the company’s stock were exchanged, compared to its average volume of 2,080,823. The firm has a market cap of $98.30 billion, a price-to-earnings ratio of 26.41, a PEG ratio of 3.47 and a beta of 0.27. The stock has a 50-day simple moving average of $274.12 and a 200 day simple moving average of $271.81. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 1-year low of $227.89 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.68 EPS. On average, equities analysts forecast that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director William R. Shepard purchased 251 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the transaction, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Institutional investors have recently modified their holdings of the business. Norges Bank bought a new stake in CME Group during the second quarter worth $1,571,447,000. Sanders Capital LLC bought a new position in CME Group in the 3rd quarter valued at $1,006,932,000. Strive Asset Management LLC bought a new position in CME Group in the 3rd quarter valued at $636,487,000. Mawer Investment Management Ltd. increased its position in shares of CME Group by 107.2% during the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after purchasing an additional 777,571 shares during the last quarter. Finally, Viking Global Investors LP bought a new stake in shares of CME Group during the 2nd quarter worth $164,648,000. 87.75% of the stock is owned by institutional investors.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME plans to list futures on Cardano (ADA), Chainlink (LINK) and Stellar (XLM) on Feb. 9 (pending approval), including both standard and micro contract sizes — broadening its regulated crypto derivatives suite and targeting rising investor demand for altcoin exposure. Cointelegraph: CME Group plans launch of Cardano, Chainlink and Stellar futures
• Positive Sentiment: CME issued a formal press release announcing the altcoin futures expansion, reinforcing management’s push to capture more digital-asset trading volume and fees across both institutional and retail segments. PR Newswire: CME Group to Expand Crypto Derivatives Suite
• Positive Sentiment: TD Cowen upgraded CME from Hold to Buy and raised its price target to $305, signaling confidence in CME’s revenue mix and product pipeline (positive analyst support). MSN: TD Cowen upgrades CME Group
• Positive Sentiment: CME is launching a smaller silver futures contract to tap surging retail interest in silver — a move that could increase trading volumes and fee income in metals. Bitcoin.com: Silver Gets a Major Upgrade
• Neutral Sentiment: Morgan Stanley trimmed its price target slightly (from $320 to $319) but kept an Overweight rating, a modest tweak that maintains institutional support but signals little change to the long-term thesis. The Fly: Morgan Stanley price target change
• Neutral Sentiment: Analysts expect single-digit bottom-line growth for Q4; the upcoming earnings release will be a near-term catalyst as investors watch revenue mix (crypto, metals, rates) and trading volumes. Barchart: What to expect from CME Group’s next earnings report
• Negative Sentiment: CME tightened margin calculations in the silver market, linking requirements more closely to price — a risk control move that could damp speculative volume and near-term trading activity in precious metals. Benzinga: CME changes margin calculation for silver
• Negative Sentiment: Despite product launches and upgrades, muted trading volume and broader market pressures appear to be weighing on the stock today — suggesting investors are awaiting concrete volume/fee lifts or the upcoming quarterly results before bidding the shares higher. No external link

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.